8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 25, 2024

WALGREENS BOOTS ALLIANCE, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-36759	47-1758322
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)

108 Wilmot Road, Deerfield, Illinois	60015
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (847) 315-2500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	WBA	The Nasdaq Stock Market LLC
3.600% Walgreens Boots Alliance, Inc. notes due 2025	WBA25	The Nasdaq Stock Market LLC
2.125% Walgreens Boots Alliance, Inc. notes due 2026	WBA26	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

(a) Walgreens Boots Alliance, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”) on January 25, 2024.

(b) Set forth below are the voting results for each of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting:

Proposal No. 1: The stockholders elected each of the following directors to serve on the Company’s Board of Directors (the “Board”) until the next Annual Meeting of Stockholders or until such director’s respective successor is elected and qualified (or any such director’s earlier death, resignation or removal):

	Votes For		Votes Against		Abstentions		Broker Non-Votes
Janice M. Babiak		578,447,830		19,753,623		1,932,566		128,393,075
Inderpal S. Bhandari		583,121,897		15,045,688		1,966,434		128,393,075
Ginger L. Graham		554,082,572		44,214,380		1,837,067		128,393,075
Bryan C. Hanson		583,761,189		14,399,693		1,973,137		128,393,075
Robert L. Huffines		590,176,727		7,963,116		1,994,176		128,393,075
Valerie B. Jarrett		576,900,299		21,446,824		1,786,896		128,393,075
John A. Lederer		577,621,999		20,582,282		1,929,738		128,393,075
Stefano Pessina		573,698,218		24,456,236		1,979,565		128,393,075
Thomas E. Polen		589,008,917		9,059,474		2,065,628		128,393,075
Nancy M. Schlichting		563,453,146		34,825,793		1,855,080		128,393,075
Timothy C. Wentworth		589,730,405		8,678,203		1,725,411		128,393,075

Proposal No. 2: The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2024 was approved. There were 698,696,401 votes for, 27,533,155 votes against, and 2,297,538 abstentions.

Proposal No. 3: The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers, as set forth in the proxy statement for the Annual Meeting, was approved. There were 518,519,997 votes for, 77,745,201 votes against, and 3,868,821 abstentions. There were 128,393,075 broker non-votes on this proposal.

Proposal No. 4: The proposal for stockholders to vote, on an advisory basis, on the frequency of future advisory votes on named executive officer compensation received the following votes: 1 year, 590,261,297; 2 years, 2,041,978; 3 years, 5,195,788; and 2,634,956 abstentions. There were 128,393,075 broker non-votes on this proposal.

Proposal No. 5: The stockholder proposal requesting a report on cigarette waste was not approved. There were 35,848,164 votes for, 558,663,096 votes against, and 5,622,759 abstentions. There were 128,393,075 broker non-votes on this proposal.

Proposal No. 6: The stockholder proposal requesting an independent board chairman was not approved. There were 188,803,480 votes for, 408,663,120 votes against, and 2,667,419 abstentions. There were 128,393,075 broker non-votes on this proposal.

Proposal No. 7: The stockholder proposal requesting a living wage policy was not approved. There were 56,709,115 votes for, 529,608,484 votes against, and 13,816,420 abstentions. There were 128,393,075 broker non-votes on this proposal.

Proposal No. 8: The stockholder proposal requesting an EEO policy risk report was not approved. There were 8,163,750 votes for, 586,124,153 votes against, and 5,846,116 abstentions. There were 128,393,075 broker non-votes on this proposal.

Proposal No. 9: The stockholder proposal requesting a report on risks of reproductive healthcare legislation was not approved. There were 46,302,172 votes for, 545,829,477 votes against, and 8,002,370 abstentions. There were 128,393,075 broker non-votes on this proposal.

(d) Following the stockholder vote on Proposal No. 4 described in Item 5.07(b) above, the Board determined that stockholder advisory votes regarding the compensation of the Company’s named executive officers (“say-on-pay” votes) will be held each year at the Company’s Annual Meeting of Stockholders until the next advisory vote of stockholders is held regarding the frequency of stockholder say-on-pay votes.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	WALGREENS BOOTS ALLIANCE, INC.
Date: January 31, 2024	By:	/s/ Joseph B. Amsbary Jr.
	Name:	Joseph B. Amsbary Jr.
	Title:	Senior Vice President, Corporate Secretary

XML

Document and Entity Information	Jan. 25, 2024
Document And Entity Information [Line Items]
Amendment Flag	false
Entity Central Index Key	0001618921
Document Type	8-K
Document Period End Date	Jan. 25, 2024
Entity Registrant Name	WALGREENS BOOTS ALLIANCE, INC.
Entity Incorporation State Country Code	DE
Entity File Number	001-36759
Entity Tax Identification Number	47-1758322
Entity Address, Address Line One	108 Wilmot Road
Entity Address, City or Town	Deerfield
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60015
City Area Code	(847)
Local Phone Number	315-2500
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Common Stock [Member]
Document And Entity Information [Line Items]
Security 12b Title	Common Stock, $0.01 par value
Trading Symbol	WBA
Security Exchange Name	NASDAQ
A 3600 Notes Payable Due 2025 [Member]
Document And Entity Information [Line Items]
Security 12b Title	3.600% Walgreens Boots Alliance, Inc. notes due 2025
Trading Symbol	WBA25
Security Exchange Name	NASDAQ
A 2125 Notes Payable Due 2026 [Member]
Document And Entity Information [Line Items]
Security 12b Title	2.125% Walgreens Boots Alliance, Inc. notes due 2026
Trading Symbol	WBA26
Security Exchange Name	NASDAQ